Peptide Academy · Growth
Also known as Recombinant IGF-1 / Increlex
Educational research summary, not medical advice. Many compounds here are not approved for human use. Talk to a licensed clinician before making any health decision.
The Peptide Academy is free to read. Members also get the research protocols for Mecasermin, dose and vial tracking, and an AI Advisor with cited sources. Try it all free for 7 days, no card needed.
Start my free 7-day trialPharmaceutical recombinant IGF-1 approved for severe primary IGF-1 deficiency.
Directly activates IGF-1 receptors, driving anabolism and linear growth independent of GH.
Prescription-only; hypoglycemia risk; WADA-prohibited.
Common side effects
Histamine reactions
Occasional injection-site redness or itching.
Common fixes
Stop and get help
Basis: Prescribing information (somatropin, mecasermin) and clinical studies. Educational only, not medical advice.
Insulin and other diabetes medicines
IGF-1 lowers blood sugar like insulin does; together they raise the risk of severe lows. Take it with a meal or snack, as the mecasermin label directs.
Alcohol and skipped meals
Both make low blood sugar more likely.
Medicines cleared by liver CYP450 enzymes (seizure medicines, cyclosporine, sex hormones, corticosteroids)
Growth hormone may change how fast these are cleared. Levels may need monitoring.
Everything else you take, including supplements
Bring a full list of medicines and supplements to your pharmacist or clinician before starting.
Basis: FDA prescribing information for Increlex (mecasermin); research IGF-1 analogs are assumed to behave similarly. Educational only, not medical advice. Never stop or change a prescribed medicine without your prescriber.
Protocols & tracking are members-only
Members see the research protocols for Mecasermin, plan schedules, track every dose and vial, and ask the AI Advisor questions with cited sources. Try every Researcher feature free for 7 days, no card needed.